A new trial saw clinicians give an identity to the voices being heard by those experiencing acute psychosis in an attempt to ...

In vivo cell therapy is a new way of delivering cell therapy, but the actual therapies don’t need to be new. In theory, ...

AgenT-797 combined with bispecific engagers targeting antigens such as MUC16, HER2, Claudin 18.2, and DLL3, promote increased ...

ICER has given tabelecleucel a rating of A, indicating the T cell therapy for Epstein-Barr virus related post-transplant ...

Humanistic therapy grew from humanistic psychology, a perspective of psychology that focuses on the individual and their inherent capacity to actualize themselves in their own unique ways. Humanistic ...

The founder of Well-Read Black Girl and author of Gather Me takes our literary survey.

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.

Notch Therapeutics, Inc., a biotechnology company developing best-in-class T cell therapies for cancer and autoimmune conditions, is excited to announce the acceptance of two abstracts by the American ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the ...

Cellenkos® Inc., a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory (Treg) cell therapies for inflammatory disease areas of high unmet needs and ...

BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) (NASDAQ:BRTX), a clinical stage regenerative ...